Viromed Medical AG: Cooperation between relyon plasma GmbH and Viromed Medical GmbH Pinneberg/Regensburg, 5 December 2024 –Viromed Medical AG (Ticker: VMED; ISIN: DE000A3MQR65) is pleased to inform about the cooperation between its subsidiary Viromed Medical GmbH and relyon plasma GmbH, a subsidiary of TDK Electronics AG (link to the original news [ … ]

Viromed Medical AG is expanding its Management Board – Christian Strauch has been appointed as a new member of the Management Board Pinneberg, 3 December 2024 – The Supervisory Board of Viromed Medical AG (Ticker: VMED; ISIN: DE000A3MQR65; “Viromed”) has appointed Mr. Christian Strauch as a new member of the company's Management Board with effect  [ … ]

Viromed Medical AG: cold plasma as a digital antibiotic for the lungs Innovative prevention measure for ventilator-associated pneumonia reaches next stage Use of cold plasma can prevent tens of thousands of deaths in Germany alone Study led by expert from the renowned research network BREATH, Hortense Slevogt Pinneberg, 26 November 2024 – Virom [ … ]

Viromed Medical AG: Successful start of trading on XETRA   Listing on leading German financial market increases liquidity and expands investor base Aiming to expand its pioneering role in the medical use of cold plasma technology Pinneberg, 2 September 2024 – Viromed Medical AG (Ticker: VMED; ISIN: DE000A3MQR65; “Viromed”) has reached another mil [ … ]

Viromed Medical AG seeks special approval for cold plasma device for the prevention of ventilator-associated pneumonia (VAP) Targeted use of the antimicrobial effect of cold plasma beyond wound treatment Use of cold plasma could revolutionize the treatment of VAP and significantly reduce mortality Aiming for rapid special approval for own devic [ … ]

Viromed Medical AG reaches important milestone – agreement with CORIUS Group for exclusive use of Plasma Care® by Viromed with significant growth potential Pinneberg, 22 April 2024 – Viromed Medical AG (ISIN: DE000A3MQR65) has concluded an agreement with CORIUS Group for the exclusive use of the pioneering cold plasma therapy with Plasma Care® by V [ … ]